Does taking Tadalafil (Cialis) 5mg occasionally increase the risk of heart disease or cataracts?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Occasional Use of Tadalafil 5mg and Risk of Heart Disease or Cataracts

Occasional use of tadalafil 5mg is not associated with an increased risk of heart disease or cataracts when used appropriately in patients without contraindications.

Cardiovascular Safety Profile

Tadalafil is a phosphodiesterase type-5 (PDE-5) inhibitor that works by enhancing the effects of nitric oxide, causing vasodilation through increased cGMP levels 1. When evaluating its cardiovascular safety:

  • Multiple clinical trials have demonstrated that tadalafil has minimal blood pressure-lowering effects in healthy individuals 2
  • A comprehensive retrospective analysis of 36 clinical trials involving 12,487 men showed the incidence rate of serious cardiovascular events was 0.40/100 patient-years in tadalafil-treated patients compared to 0.43/100 patient-years in placebo-treated patients 3
  • The cardiovascular safety profile remains consistent regardless of dosing regimen (as needed, three times weekly, or once daily) 3

Important Cardiovascular Considerations

While tadalafil is generally safe from a cardiovascular perspective, there are important contraindications:

  • Absolute contraindication: Combination with nitrates or nitric oxide donors due to risk of severe hypotension (requires at least 48 hours between tadalafil and nitrate use) 1, 2
  • Caution in patients with uncontrolled hypertension, recent stroke (within 6 months), or significant cardiac disease 1
  • Careful monitoring when combined with alpha-blockers like doxazosin 2

Ocular Safety and Cataract Risk

The available evidence does not indicate an increased risk of cataracts with tadalafil use:

  • PDE-5 inhibitors like tadalafil are contraindicated in patients who have experienced sudden vision loss due to anterior ischemic optic neuropathy, but this is distinct from cataract formation 1
  • None of the clinical guidelines or research evidence provided mentions cataracts as a reported adverse effect of tadalafil

Common Side Effects

When used occasionally at 5mg dosage, tadalafil's side effect profile is generally mild:

  • Most common side effects include headache, flushing, dyspepsia (indigestion), back pain, and myalgia 4, 5
  • Side effects appear to be age-dependent, with older patients (>55 years) more commonly reporting gastrointestinal upset 5
  • In clinical trials, only 3.4% of patients discontinued treatment due to adverse events 4

Special Considerations for Occasional Use

For patients considering occasional use of tadalafil 5mg:

  1. Pre-existing cardiovascular disease: Complete cardiovascular evaluation may be necessary before prescribing tadalafil 2
  2. Medication interactions: Avoid combining with nitrates, use caution with alpha-blockers and certain antihypertensives 1, 2
  3. Dosing flexibility: The 5mg dose is well-tolerated and effective for most patients with erectile dysfunction 4, 5

Conclusion

Based on the available evidence, occasional use of tadalafil 5mg does not increase the risk of heart disease or cataracts in appropriate patients without contraindications. The cardiovascular safety profile has been well-established through multiple clinical trials, showing similar rates of cardiovascular events between tadalafil and placebo groups 3. No evidence suggests an increased risk of cataracts with tadalafil use.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.